Antiporte, Julito F.

HRN: 23-86-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/02/2026
07/09/2026
IV
500mg
Q8
Intraabdominal Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: